News | June 21, 2026
Evonik sells Hanau pharma assets to ProChem in strategic portfolio shift
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets
The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances
As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market
Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
